The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - OPKO Diagnostics
Speakers' Bureau - Astellas Oncology; BMS GmbH & Co. KG; Ipsen; Janssen; MSD
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ipsen; Janssen
Cabozantinib in patients with locally advanced or metastatic urothelial cell carcinoma who have progressed after cisplatin-based chemotherapy and anti-PD-1/PD-L1 therapy or after anti-PD-1/PD-L1 therapy only.
 
Georg Bartsch
No Relationships to Disclose
 
Christian Thomas
Stock and Other Ownership Interests - Orion Biotechnology
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - BMSi; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Igor Tsaur
Consulting or Advisory Role - Astellas Oncology; Janssen; MSD; Pfizer; Sanofi Aventis GmbH
Speakers' Bureau - Astellas Oncology; Janssen; Pfizer; Sanofi Aventis GmbH
Travel, Accommodations, Expenses - Astellas Oncology; Ipsen; Janssen; Pfizer
 
Marco Schnabel
No Relationships to Disclose
 
Axel Haferkamp
No Relationships to Disclose
 
Stanislav Gorbulev
No Relationships to Disclose
 
Christian Ruckes
No Relationships to Disclose
 
Kai Kronfeld
No Relationships to Disclose